Arkolith/Insider Trading/FDMT/Form 4

Ra Capital Management, L.P.

10% Owner4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Dec 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2024Other(J)535K—$04.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2024Other(J)535K——3.6M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-028837) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML